BioPharma Pharma QC

GC Biopharma Receives WHO Pre-Qualification for BARYCELA

WHO prequalification decision has made BARYCELA now eligible for procurement by the United Nations agencies, including the Pan American Health Organization...

 February 20, 2023 | News

Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity

 The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, a...

 February 17, 2023 | News

GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea

This plant is the largest filling and finish facility based in South Korea, established in 2019. GC Biopharma installed an isolator facilities and app...

 February 09, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

 February 03, 2023 | News

Bionomics Released Quarterly Activities and Cashflow Report

Released its Appendix 4C – Quarterly Cashflow Report. Highlights during the Quarter ended 31 December 2022 (Quarter) and up to the date of this annou...

 January 31, 2023 | News

Lecanemab Receives Priority Review Status in Japan

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...

 January 30, 2023 | News

Alpha Biopharma Submits New Drug Application for Zorifertinib

Alpha Biopharma, a developer of innovative drugs, announces that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA...

 January 30, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

 January 26, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

 January 23, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

 January 23, 2023 | News

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC

  World's first anti-PD-1 mAb for the first-line treatment of SCLC Making a new record with the median OS of 15.8 months in an international, mult...

 January 18, 2023 | News

6 Must-Haves for a Quality Management System

Choose the best one for your business by learning about the 6 essentials that an eQMS needs to be effective. If an eQMS doesn't check the...

 January 18, 2023 | News

FDA Accepts GMP Plasmid DMF of OBiO Technology

OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', 688238.SH), a gene and cell therapy-focused contract research organization (CRO) and contract development a...

 January 17, 2023 | News

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Agilent Technologies Inc. (NYSE: A)  announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nuclei...

 January 13, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close